EPIRUS Biopharmaceuticals, Inc. Long-Term Debt
EPIRUS Biopharmaceuticals, Inc. had Long-Term Debt of $12.57 million as of 2015-09-30, per its 10-Q filed 2015-11-16.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:LongTermDebtNoncurrent · last filed 2016-03-29
- 2015-09-30: Long-term Debt, Excluding Current Maturities $12.57M.
- 2015-06-30: Long-term Debt, Excluding Current Maturities $13.92M.
- 2015-03-31: Long-term Debt, Excluding Current Maturities $7.30M.
- 2014-12-31: Long-term Debt, Excluding Current Maturities $7.27M; Long-term Debt, Excluding Current Maturities as first filed $7.28M.
| Period end | Long-term Debt, Excluding Current Maturities | Long-term Debt, Excluding Current Maturities as first filed |
|---|---|---|
| 2015-09-30 | $12.57M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $13.92M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $7.30M 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $7.27M 10-K · filed 2016-03-29 | $7.28M 10-K · filed 2015-03-31 |